billHR8317Event Wednesday, April 15, 2026Analyzed

Tech to Save Moms Act

Neutral
Impact4/10

Summary

HR8317, the Tech to Save Moms Act, has been introduced in the House and referred to the Committee on Energy and Commerce. The bill authorizes grants for technology-enabled collaborative learning and capacity building models to improve maternal health outcomes, particularly in underserved areas. No specific funding amount is authorized, and actual appropriations would be required for implementation.

See which stocks are affected

Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.

Already have an account? Log in

Key Takeaways

  • 1.HR8317, the Tech to Save Moms Act, has been introduced in the House and referred to the Energy and Commerce Committee.
  • 2.The bill authorizes grants for technology-enabled collaborative learning and capacity building models to improve maternal health outcomes, but does not appropriate funds.
  • 3.Companies in the telehealth and health technology sectors are potential beneficiaries if the bill passes and receives appropriations.

Market Implications

The introduction of HR8317 signals legislative intent to expand the use of technology in maternal healthcare. Should this bill advance and receive appropriations, it would create new grant opportunities for eligible entities to adopt and expand telehealth solutions. This could translate into increased demand for services from telehealth providers like Teladoc Health ($TDOC) and Amwell ($AMWL), as well as companies offering remote monitoring and diagnostic technologies. The bill's focus on underserved populations could open new market segments for these companies. However, as the bill is in an early stage and only authorizes grants without appropriating funds, any market impact is currently speculative and contingent on future legislative action.

Full Analysis

HR8317, titled the "Tech to Save Moms Act," was introduced in the House of Representatives on April 15, 2026, by Rep. Nikema Williams (D-GA-5) and 24 cosponsors. It has been referred to the House Committee on Energy and Commerce, indicating an early stage in the legislative process. The bill aims to amend the Public Health Service Act to authorize grants for evaluating, developing, and expanding the use of technology-enabled collaborative learning and capacity building models to improve maternal health outcomes, especially in health professional shortage areas, rural and underserved areas, and for medically underserved populations. The bill itself does not appropriate any funds but rather authorizes the Secretary to award grants. This means that while the policy framework for supporting telehealth and technology in maternal care is being established, actual funding for these grants would depend on subsequent appropriations bills. The grants are intended to support training, infrastructure, and program development related to telehealth tools for screening, monitoring, and managing health complications during pregnancy and up to one year postpartum. The bill also amends the Social Security Act to include the adoption and use of telehealth tools for maternal care under Title XIX, with an effective date one year after enactment. Structural beneficiaries of this legislation, should it pass and be funded, would include companies involved in telehealth services, health technology platforms, and medical device manufacturers that support remote monitoring and diagnostics. Pure-play telehealth providers such as Teladoc Health ($TDOC) and Amwell ($AMWL) would be direct beneficiaries. Additionally, companies providing remote patient monitoring solutions or diagnostic services, like Livongo Health (now part of Teladoc Health, $TDOC) or contract research organizations involved in evaluating health outcomes such as LabCorp ($LH) or Quest Diagnostics ($OMCL), could see increased demand for their services. The bill's focus on underserved areas and specific populations suggests a potential for market expansion in these segments. Given its early stage, with referral to committee, the bill's timeline for passage is uncertain. However, the presence of a related Senate bill, S958, also titled the "Tech to Save Moms Act," suggests bipartisan and bicameral interest in the policy area, which could increase its chances of advancing. The related bill HR7973, the "Momnibus Act," also addresses maternal health and has been referred to multiple committees, indicating a broader legislative push on this issue. There are no recent presidential actions directly relevant to maternal health or telehealth that would amplify or conflict with this legislative activity.

Market Impact Score

4/10
Minimal ImpactModerateMajor Market Event

Related Presidential Actions

Executive orders & memoranda affecting the same sectors or companies

Exec OrderApr 18, 2026

Accelerating Medical Treatments for Serious Mental Illness

This executive order directs the FDA to prioritize review and facilitate 'Right to Try' access for psychedelic drugs, including ibogaine compounds, that have received Breakthrough Therapy designation for serious mental illnesses. It also allocates $50 million from HHS to support state programs advancing these treatments and mandates collaboration between HHS, FDA, VA, and the private sector to increase clinical trial participation and data sharing for these drugs. The Attorney General is further directed to expedite rescheduling reviews for approved Schedule I psychedelic substances.